ADAMTS 13缺乏与新型冠状病毒肺炎患者血管性血友病因子多聚体的异常分布有关。 - Suppr

Suppr

超能文献

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19.

作者信息

Pascreau Tiffany, Zia-Chahabi Sara, Zuber Benjamin, Tcherakian Colas, Farfour Eric, Vasse Marc

机构信息

Department of Clinical Biology, Foch Hospital, Suresnes, France; INSERM UMR_S1176, Le Kremlin-Bicêtre, France.

Department of Clinical Biology, Foch Hospital, Suresnes, France.

出版信息

Thromb Res. 2021 Aug;204:138-140. doi: 10.1016/j.thromres.2021.02.008. Epub 2021 Feb 9.

DOI:10.1016/j.thromres.2021.02.008

PMID:33583574

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7871804/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc57/7871804/36a5c4b0f14a/gr1_lrg.jpg

相似文献

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19.ADAMTS 13缺乏与新型冠状病毒肺炎患者血管性血友病因子多聚体的异常分布有关。

Thromb Res. 2021 Aug;204:138-140. doi: 10.1016/j.thromres.2021.02.008. Epub 2021 Feb 9.

Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research.蒂芙尼·帕斯克罗等人所著《ADAMTS13缺乏与COVID-19患者血管性血友病因子多聚体的异常分布相关》的特邀评论。致《血栓形成研究》主编的信。

Thromb Res. 2021 Aug;204:141-142. doi: 10.1016/j.thromres.2021.02.030. Epub 2021 Mar 3.

Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.左心室辅助装置导致病理性血管性血友病因子降解是通过两种不同的机制发生的：机械破坏和酶切。

J Thorac Cardiovasc Surg. 2015 Jan;149(1):281-9. doi: 10.1016/j.jtcvs.2014.09.031. Epub 2014 Sep 18.

Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.妊娠期 COVID-19 孕妇的产科结局：血管性血友病因子和 ADAMTS13 轴的失衡。

BMC Pregnancy Childbirth. 2022 Feb 21;22(1):142. doi: 10.1186/s12884-022-04405-8.

Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.COVID-19 中 VWF 的增加和 ADAMTS-13 的减少：为（微）血栓形成创造了环境。

Semin Thromb Hemost. 2021 Jun;47(4):400-418. doi: 10.1055/s-0041-1727282. Epub 2021 Apr 23.

Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.血管性血友病因子、ADAMTS-13 和血栓性血小板减少性紫癜。

Semin Thromb Hemost. 2010 Feb;36(1):71-81. doi: 10.1055/s-0030-1248726. Epub 2010 Apr 13.

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.中重度新冠肺炎患者血管性血友病因子/凝血因子Ⅷ裂解酶轴与静脉血栓栓塞症

Br J Haematol. 2021 Mar;192(6):1097-1100. doi: 10.1111/bjh.17216. Epub 2020 Dec 24.

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.免疫血栓形成的新见解：中性粒细胞胞外诱捕网、血管性血友病因子与 ADAMTS13 的相互作用。

Front Immunol. 2020 Dec 2;11:610696. doi: 10.3389/fimmu.2020.610696. eCollection 2020.

Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.左心室辅助装置（LVAD）导致的获得性血管性血友病因子缺乏是依赖于ADAMTS-13和血小板的。

Thromb Res. 2016 Jan;137:196-201. doi: 10.1016/j.thromres.2015.11.002. Epub 2015 Nov 10.

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.ADAMTS-13在流动条件下能迅速切割内皮表面新分泌的超大血管性血友病因子多聚体。

Blood. 2002 Dec 1;100(12):4033-9. doi: 10.1182/blood-2002-05-1401. Epub 2002 Jul 25.

引用本文的文献

To Gain Insights into the Pathophysiological Mechanisms of the Thrombo-Inflammatory Process in the Atherosclerotic Plaque.深入了解动脉粥样硬化斑块中血栓炎症过程的病理生理机制。

Int J Mol Sci. 2023 Dec 19;25(1):47. doi: 10.3390/ijms25010047.

Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association.低密度脂蛋白通过增强血管性血友病因子的自缔合促进微血管血栓形成。

Blood. 2023 Sep 28;142(13):1156-1166. doi: 10.1182/blood.2023019749.

Von Willebrand factor and the thrombophilia of severe COVID-19: evidence from autopsies.血管性血友病因子与重症新型冠状病毒肺炎的血栓形成倾向：尸检证据

Res Pract Thromb Haemost. 2023 May;7(4):100182. doi: 10.1016/j.rpth.2023.100182. Epub 2023 May 18.

Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19.恢复期血浆输注对重症和危重症新型冠状病毒肺炎患者中ADAMTS13-血管性血友病因子轴及内皮完整性的影响

Res Pract Thromb Haemost. 2023 Jan;7(1):100010. doi: 10.1016/j.rpth.2022.100010. Epub 2022 Dec 13.

Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.COVID-19 患者血管性血友病因子和 ADAMTS13 的预后价值：系统评价和荟萃分析。

Thromb Res. 2022 Oct;218:83-98. doi: 10.1016/j.thromres.2022.08.017. Epub 2022 Aug 18.

COVID-19-Associated Thrombotic Thrombocytopenic Purpura: A Case Report and Systematic Review.新型冠状病毒肺炎相关血栓性血小板减少性紫癜：一例报告及系统评价

Hematol Rep. 2022 Aug 2;14(3):253-260. doi: 10.3390/hematolrep14030035.

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.血管内皮和凝血：稳态、疾病和治疗，重点关注血管性血友病因子和因子 VIII 和 V。

Int J Mol Sci. 2022 Jul 27;23(15):8283. doi: 10.3390/ijms23158283.

Thromboinflammation: From Atherosclerosis to COVID-19.血栓炎症：从动脉粥样硬化到 COVID-19。

Arterioscler Thromb Vasc Biol. 2022 Sep;42(9):1103-1112. doi: 10.1161/ATVBAHA.122.317162. Epub 2022 Jul 8.

Carriers of Rare Variants Are at High Risk of Life-Threatening COVID-19.罕见变异携带者有发生危及生命的 COVID-19 的高风险。

Viruses. 2022 May 29;14(6):1185. doi: 10.3390/v14061185.

Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19: A Retrospective Observational Study.ADAMTS13 活性降低与 COVID-19 的病理生理学、严重程度和结局的相关性：一项回顾性观察研究。

Int J Infect Dis. 2022 Apr;117:334-344. doi: 10.1016/j.ijid.2022.02.019. Epub 2022 Feb 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验